elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34851156-22A14115-8A67-4F5F-A56B-FE95EA94972E
Q34851156-22A14115-8A67-4F5F-A56B-FE95EA94972E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34851156-22A14115-8A67-4F5F-A56B-FE95EA94972E
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
P433
Q34851156-22A14115-8A67-4F5F-A56B-FE95EA94972E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34851156-22A14115-8A67-4F5F-A56B-FE95EA94972E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55c8bf80f023ea9a1368c24d21b655cb13898cbb
P433
4
http://www.w3.org/2001/XMLSchema#string